UFP Technologies, Inc. (UFPT) Q3 2025 Earnings Call Transcript
Overall Sales $154.6 million, a 6.5% increase year-over-year. Growth attributed to MedTech business growth and offset by a decline in Advanced Components.
MedTech Business Growth 7.3% increase year-over-year. Growth driven by Interventional and Surgical, Orthopedics, and Wound Care, each growing over 30%, offset by a 23% decline in Patient Services and Support.
Advanced Components (Non-Medical Business) 2.7% decline year-over-year. Decline due to resource focus on MedTech business.
AJR Labor Inefficiency Impact $3 million reduction in gross profit and operating income, and a $0.28 reduction in diluted EPS. Caused by workforce turnover and retraining due to e-verify process.
Robotic Surgery Revenue 5.1% increase year-over-year. Growth attributed to the launch of two significant new programs.
Organic Growth Flat year-over-year. AJR sales reduction offset growth. Without AJR issues, organic sales would have grown approximately 6%.
Gross Margin 27.7%, a decrease due to $3 million in extra labor costs at AJR. Without these costs, gross margin would have been 29.6%.
Adjusted Operating Margin 17% of sales, within target range despite $3 million in extra labor costs.
Interest Expense Significantly decreased year-over-year due to deleveraging the balance sheet.
Effective Tax Rate 22.2%, slightly down from the previous year.
Cash from Operations $35.9 million generated during the quarter.
Debt Reduction $17.5 million paid down during the quarter.
Capital Expenditures $3.4 million during the quarter.
Trade with 70% Backtested Accuracy
Analyst Views on UFPT
About UFPT
About the author
UFP Technologies: Small-Cap Medical Device Stock with 10-Bagger Potential
- Outstanding Market Performance: Since its IPO in 1993, UFP Technologies has seen its stock price grow 44-fold, achieving a 12-bagger over the past decade, despite a market cap of only $2 billion, highlighting its immense potential as a small-cap stock.
- Strong Customer Base: UFP collaborates with 26 of the top 30 medical original equipment manufacturers, allowing it to select high-margin product development opportunities, thereby enhancing its market competitiveness and profitability.
- Diversified Business Lines: UFP's robot-assisted surgical drapes account for 29% of its sales, and with the industry projected to double by 2029, UFP's market share in this sector is set to expand further.
- Successful Acquisition Strategy: Since 2021, UFP has made nine acquisitions, quadrupling its medtech sales and demonstrating a successful track record of expanding production capabilities through acquisitions, while a 26% sales growth over the past year indicates its underlying value despite flat stock performance.
Potential Shift in the Bullish Outlook for UFP Technologies (UFPT) Amid Labor Disruptions and Upcoming Contract Negotiations
Labor Disruptions and Financial Impact: UFP Technologies experienced significant labor disruptions at its AJR Illinois facility, resulting in an estimated US$3 million profit impact and operational challenges, while still pursuing a potential expansion of a US$500 million contract with Intuitive Surgical.
Growth Projections: The company anticipates reaching $694.3 million in revenue and $96.3 million in earnings by 2028, reflecting a projected annual growth rate of 5.7%, with a fair value estimate ranging from US$329.50 to US$524.77.
Investment Considerations: Investors are encouraged to consider UFP Technologies' role as a key supplier in robotic-assisted surgery, while also being mindful of ongoing operational risks related to workforce stability that could affect performance.
Research and Analysis Tools: Simply Wall St offers a comprehensive analysis of UFP Technologies, including key rewards and risks, and provides a visual summary of the company's financial health to assist investors in their decision-making process.
Transcript of UFP Tech (UFPT) Earnings Call for Q3 2025
- Author's Perspective: The views and opinions presented are solely those of the author.
- No Official Endorsement: The content does not necessarily reflect the views of Nasdaq, Inc.
Packaging Corp. (PKG) Reports Q3 Earnings Below Expectations
Earnings Performance: Packaging Corp. (PKG) reported quarterly earnings of $2.73 per share, missing the Zacks Consensus Estimate of $2.83, but showing an increase from $2.65 per share a year ago. The company experienced a -3.53% earnings surprise this quarter.
Revenue Growth: The company achieved revenues of $2.31 billion for the quarter, exceeding the Zacks Consensus Estimate by 2.17% and up from $2.18 billion year-over-year. Packaging Corp. has surpassed revenue estimates in four consecutive quarters.
Stock Outlook: Despite underperforming the market with a 7.6% decline since the start of the year, Packaging Corp. holds a Zacks Rank #2 (Buy), indicating expectations for future outperformance based on favorable earnings estimate revisions.
Industry Context: The Containers - Paper and Packaging industry ranks in the top 39% of Zacks industries, suggesting a positive outlook that could influence Packaging Corp.'s stock performance, alongside the upcoming earnings report from UFP Technologies (UFPT).
JMEE's Core Assets May Indicate 11% Growth Opportunity
ETF Analyst Target Price: The JPMorgan Market Expansion Enhanced Equity ETF (JMEE) has an implied analyst target price of $70.97 per unit, indicating an 11.00% upside from its recent trading price of $63.94.
Notable Holdings with Upside: Key underlying holdings of JMEE, such as Vir Biotechnology Inc (VIR), UFP Technologies Inc (UFPT), and Palomar Holdings Inc (PLMR), show significant potential for price increases based on analyst targets, with upside estimates of 232.47%, 49.92%, and 42.73% respectively.
Are Options Traders Anticipating a Surge in UFP Technologies Stock?
Implied Volatility in Options Market: UFP Technologies, Inc. (UFPT) is experiencing high implied volatility in its options market, particularly with the Oct 17, 2025 $240 Call, indicating that investors expect significant price movement in the near future.
Analyst Sentiment and Earnings Estimates: Currently rated as a Zacks Rank #3 (Hold), UFP Technologies has seen no upward revisions in earnings estimates over the past 60 days, with the consensus estimate dropping from $2.47 to $2.22 per share, suggesting cautious sentiment among analysts.
UFP Technologies: Small-Cap Medical Device Stock with 10-Bagger Potential
- Outstanding Market Performance: Since its IPO in 1993, UFP Technologies has seen its stock price grow 44-fold, achieving a 12-bagger over the past decade, despite a market cap of only $2 billion, highlighting its immense potential as a small-cap stock.
- Strong Customer Base: UFP collaborates with 26 of the top 30 medical original equipment manufacturers, allowing it to select high-margin product development opportunities, thereby enhancing its market competitiveness and profitability.
- Diversified Business Lines: UFP's robot-assisted surgical drapes account for 29% of its sales, and with the industry projected to double by 2029, UFP's market share in this sector is set to expand further.
- Successful Acquisition Strategy: Since 2021, UFP has made nine acquisitions, quadrupling its medtech sales and demonstrating a successful track record of expanding production capabilities through acquisitions, while a 26% sales growth over the past year indicates its underlying value despite flat stock performance.
Potential Shift in the Bullish Outlook for UFP Technologies (UFPT) Amid Labor Disruptions and Upcoming Contract Negotiations
Labor Disruptions and Financial Impact: UFP Technologies experienced significant labor disruptions at its AJR Illinois facility, resulting in an estimated US$3 million profit impact and operational challenges, while still pursuing a potential expansion of a US$500 million contract with Intuitive Surgical.
Growth Projections: The company anticipates reaching $694.3 million in revenue and $96.3 million in earnings by 2028, reflecting a projected annual growth rate of 5.7%, with a fair value estimate ranging from US$329.50 to US$524.77.
Investment Considerations: Investors are encouraged to consider UFP Technologies' role as a key supplier in robotic-assisted surgery, while also being mindful of ongoing operational risks related to workforce stability that could affect performance.
Research and Analysis Tools: Simply Wall St offers a comprehensive analysis of UFP Technologies, including key rewards and risks, and provides a visual summary of the company's financial health to assist investors in their decision-making process.
Transcript of UFP Tech (UFPT) Earnings Call for Q3 2025
- Author's Perspective: The views and opinions presented are solely those of the author.
- No Official Endorsement: The content does not necessarily reflect the views of Nasdaq, Inc.
Packaging Corp. (PKG) Reports Q3 Earnings Below Expectations
Earnings Performance: Packaging Corp. (PKG) reported quarterly earnings of $2.73 per share, missing the Zacks Consensus Estimate of $2.83, but showing an increase from $2.65 per share a year ago. The company experienced a -3.53% earnings surprise this quarter.
Revenue Growth: The company achieved revenues of $2.31 billion for the quarter, exceeding the Zacks Consensus Estimate by 2.17% and up from $2.18 billion year-over-year. Packaging Corp. has surpassed revenue estimates in four consecutive quarters.
Stock Outlook: Despite underperforming the market with a 7.6% decline since the start of the year, Packaging Corp. holds a Zacks Rank #2 (Buy), indicating expectations for future outperformance based on favorable earnings estimate revisions.
Industry Context: The Containers - Paper and Packaging industry ranks in the top 39% of Zacks industries, suggesting a positive outlook that could influence Packaging Corp.'s stock performance, alongside the upcoming earnings report from UFP Technologies (UFPT).
JMEE's Core Assets May Indicate 11% Growth Opportunity
ETF Analyst Target Price: The JPMorgan Market Expansion Enhanced Equity ETF (JMEE) has an implied analyst target price of $70.97 per unit, indicating an 11.00% upside from its recent trading price of $63.94.
Notable Holdings with Upside: Key underlying holdings of JMEE, such as Vir Biotechnology Inc (VIR), UFP Technologies Inc (UFPT), and Palomar Holdings Inc (PLMR), show significant potential for price increases based on analyst targets, with upside estimates of 232.47%, 49.92%, and 42.73% respectively.
Are Options Traders Anticipating a Surge in UFP Technologies Stock?
Implied Volatility in Options Market: UFP Technologies, Inc. (UFPT) is experiencing high implied volatility in its options market, particularly with the Oct 17, 2025 $240 Call, indicating that investors expect significant price movement in the near future.
Analyst Sentiment and Earnings Estimates: Currently rated as a Zacks Rank #3 (Hold), UFP Technologies has seen no upward revisions in earnings estimates over the past 60 days, with the consensus estimate dropping from $2.47 to $2.22 per share, suggesting cautious sentiment among analysts.
